Back to Search
Start Over
Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Figure 1. Tumor retention of PU-H71 tracer varied considerably between patients. Tumor retention expressed as tumor:bloodpool SUV ratio (y-axis) measured on PET at 4 and 24 hours post tracer-injection.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....951f22e47aec50efd05d77b9ce89c91c
- Full Text :
- https://doi.org/10.1158/1078-0432.22477818.v1